We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
New research conducted by John Hopkins University in Baltimore, US, has found that a certain group of genetic faults can be used to predict the success of immunotherapy in cancer patients.